Endocrinology, Vol 136, 1495-1501, Copyright © 1995 by Endocrine Society

ARTICLES

Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat

JA Lugg, J Rajfer and NF Gonzalez-Cadavid
Department of Surgery, University of California at Los Angeles (UCLA) School of Medicine, Harbor-UCLA Medical Center, Torrance 90509.

Androgens are essential for the expression of normal libido in the male, but their role in the maintenance of the erectile response in humans is controversial. It has been shown previously in the rat that castration induces 1) loss of penile reflexes; and 2) considerable reduction in the erectile response to electric field stimulation (EFS) of the cavernosal nerve. Both of these effects can be reversed by testosterone replacement. The current study was performed to determine whether these testosterone effects are mediated via its conversion to dihydrotestosterone (DHT), and to what extent the synthesis of the mediator of penile erection, nitric oxide, is affected by castration and androgen replacement. Five-month-old rats were either castrated or left intact. The orchiectomized rats were implanted with SILASTIC brand silicon tubing (Dow Corning) containing testosterone or DHT with or without daily injections of the 5 alpha-reductase inhibitor finasteride. After 7 days, rats were submitted to EFS and the intracavernosal pressure was recorded. Castration reduced the EFS- induced erectile response by 50% in comparison with intact rats and testosterone restored this decrease to normal. When finasteride was given to these testosterone-treated castrate rats, erectile response was not restored. DHT was as effective as testosterone in restoring response to EFS in castrates and this effect was not decreased by finasteride. Nitric oxide synthase activity in the penile cytosol was measured by the arginine-citrulline conversion and was found to correlate with the EFS determinations. These results show that DHT is the active androgen in the prevention of erectile failure seen in castrated rats, and suggest that this effect may be mediated, at least partially, by changes in nitric oxide synthase levels in the penis.

This article has been cited by other articles:

				J. Y. Polsky, K. J. Aronson, J. P. W. Heaton, and M. A. Adams Pesticides and Polychlorinated Biphenyls as Potential Risk Factors for Erectile Dysfunction J Androl, January 1, 2007; 28(1): 28 - 37. [Abstract] [Full Text] [PDF]

				J. M. Kaufman and A. Vermeulen The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications Endocr. Rev., October 1, 2005; 26(6): 833 - 876. [Abstract] [Full Text] [PDF]

				A. M. Traish, P. Toselli, S.-J. Jeong, and N. N. Kim Adipocyte Accumulation in Penile Corpus Cavernosum of the Orchiectomized Rabbit: A Potential Mechanism for Veno-occlusive Dysfunction in Androgen Deficiency J Androl, March 1, 2005; 26(2): 242 - 248. [Abstract] [Full Text] [PDF]

				N. Toda and T. Okamura The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324. [Abstract] [Full Text] [PDF]

				C. J. Wingard, J. A. Johnson, A. Holmes, and A. Prikosh Improved erectile function after Rho-kinase inhibition in a rat castrate model of erectile dysfunction Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1572 - R1579. [Abstract] [Full Text] [PDF]

				A. M. Traish, R. Munarriz, L. O'Connell, S. Choi, S. W. Kim, N. N. Kim, Y.-H. Huang, and I. Goldstein Effects of Medical or Surgical Castration on Erectile Function in an Animal Model J Androl, May 1, 2003; 24(3): 381 - 387. [Abstract] [Full Text] [PDF]

				S. Bhasin, L. Woodhouse, R. Casaburi, A. B. Singh, D. Bhasin, N. Berman, X. Chen, K. E. Yarasheski, L. Magliano, C. Dzekov, et al. Testosterone dose-response relationships in healthy young men Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1172 - E1181. [Abstract] [Full Text] [PDF]

				F. R. Kandeel, V. K. T. Koussa, and R. S. Swerdloff Male Sexual Function and Its Disorders: Physiology, Pathophysiology, Clinical Investigation, and Treatment Endocr. Rev., June 1, 2001; 22(3): 342 - 388. [Abstract] [Full Text] [PDF]

				A. Vermeulen Androgen Replacement Therapy in the Aging Male--A Critical Evaluation J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2380 - 2390. [Full Text] [PDF]

				P. Cohan and S. G. Korenman Erectile Dysfunction J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2391 - 2394. [Full Text] [PDF]

				R. Marin, A. Escrig, P. Abreu, and M. Mas Androgen-Dependent Nitric Oxide Release in Rat Penis Correlates with Levels of Constitutive Nitric Oxide Synthase Isoenzymes Biol Reprod, October 1, 1999; 61(4): 1012 - 1016. [Abstract] [Full Text]

				M. E. Sullivan, C. S. Thompson, M. R. Dashwood, M. A. Khan, J. Y. Jeremy, R. J. Morgan, and D. P. Mikhailidis Nitric oxide and penile erection: Is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res, August 15, 1999; 43(3): 658 - 665. [Abstract] [Full Text] [PDF]

				A. M. Traish, K. Park, V. Dhir, N. N. Kim, R. B. Moreland, and I. Goldstein Effects of Castration and Androgen Replacement on Erectile Function in a Rabbit Model Endocrinology, April 1, 1999; 140(4): 1861 - 1868. [Abstract] [Full Text]

				T.M. Mills, R.W. Lewis, and V.S. Stopper Androgenic Maintenance of Inflow and Veno-Occlusion during Erection in the Rat Biol Reprod, December 1, 1998; 59(6): 1413 - 1418. [Abstract] [Full Text]

				D. F. Penson, C. Ng, J. Rajfer, and N. F. Gonzalez-Cadavid Adrenal Control of Erectile Function and Nitric Oxide Synthase in the Rat Penis Endocrinology, September 1, 1997; 138(9): 3925 - 3932. [Abstract] [Full Text] [PDF]

				A. Schirar, C. Bonnefond, C. Meusnier, and E. Devinoy Androgens Modulate Nitric Oxide Synthase Messenger Ribonucleic Acid Expression in Neurons of the Major Pelvic Ganglion in the Rat Endocrinology, August 1, 1997; 138(8): 3093 - 3102. [Abstract] [Full Text] [PDF]